Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
It reduces the burden of frequent injections on research models, minimizes stress, and helps maintain steady-state concentrations of the peptide, leading to more consistent research outcomes
Takeda et al
Nooms clinical review provides a detailed breakdown of the trial data
Background: GLP-1 Receptor Agonists and Rising Obesity Treatment Demand Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of drugs that simulate a gut-derived hormone responsible for lowering blood glucose levels and suppressing appetite
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
